Landmark court decisions like Amgen v. Sanofi and Allergan v. Teva are reshaping how generic drugs enter the market, delaying access and raising prices. Learn how patent law affects what you pay for medicine.
Tag: Orange Book
Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, accelerating affordable drug access. Learn how the Hatch-Waxman Act enables this system, why it saves billions, and how companies navigate legal battles over patents.